Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ATR | Q13535 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29936543 | 1.00 | CYP3A4 (0.58) | CYP3A4ALOX15POLBALDH1A1ACHE | |
| SCHEMBL15988655 | 0.89 | CYP3A4 (0.46) | CYP3A4ALOX15POLBALDH1A1ACHE | |
| SCHEMBL4943745 | 0.85 | CYP3A4 (0.50) | CYP3A4ALOX15POLBALDH1A1ACHE | |
| SCHEMBL13473554 | 0.84 | CYP3A4 (0.62) | CYP3A4ALOX15POLBALDH1A1ACHE | |
| SCHEMBL12145090 | 0.82 | CYP3A4 (0.47) | CYP3A4ALOX15POLBALDH1A1ACHE | |
| SCHEMBL25367938 | 0.79 | CYP3A4 (0.57) | CYP3A4ALOX15POLBALDH1A1ACHE | |
| SCHEMBL25367786 | 0.77 | CYP3A4 (0.67) | CYP3A4ALOX15POLBALDH1A1ACHE | |
| SCHEMBL10000333 | 0.77 | CYP3A4 (0.43) | CYP3A4ALOX15POLBALDH1A1ACHE | |
| SCHEMBL25371015 | 0.77 | CYP3A4 (0.67) | CYP3A4ALOX15POLBALDH1A1ACHE | |
| SCHEMBL4946422 | 0.76 | POLB (0.53) | CYP3A4ALOX15POLBALDH1A1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11883418-B2 | Compound TSYI-ZAC for inhibiting dengue virus infection and medicinal use thereof | SYI BIOTECHNOLOGY CO., LTD. (TW) | 2024-01-30 | — | — | US | claimed |
| US-20230285415-A1 | COMPOUND TSYI-ZAC FOR INHIBITING DENGUE VIRUS INFECTION AND MEDICINAL USE THEREOF | SYI BIOTECHNOLOGY CO., LTD. (TW) | 2023-09-14 | — | — | US | claimed |
| US-11602520-B2 | c-Met regulatory composition and its method for treating liver disease | Greenyn Biotechnology Co., Ltd (TW) | 2023-03-14 | — | — | US | claimed |
| US-20220142971-A1 | C-MET REGULATORY COMPOSITION AND ITS METHOD FOR TREATING LIVER DISEASE | Greenyn Biotechnology Co., Ltd (TW) | 2022-05-12 | — | — | US | claimed |
| CN-113795258-A | Methods and compositions for inhibiting viral infection | 吉亚生技控股股份有限公司 | 2021-12-14 | — | — | CN | claimed |
| US-20210112832-A1 | ANTRODIA CINNAMOMEA FERMENTED BROWN RICE, PREPARING METHOD AND COMPOSITION THEREOF | KANG JIANN BIOTECH CO., LTD. (TW) | 2021-04-22 | — | — | US | claimed |
| CN-109276563-B | Application of pharmaceutical composition in preparing medicine for treating or preventing individual infection virus | 珠海市鑫展生物科技有限公司 | 2021-04-09 | — | — | CN | claimed |
| EP-3415145-A2 | METHOD FOR TREATING STROKE OR REDUCING NERVE INJURY | Arjil Biotech Holding Company Limited (TW) | 2018-12-19 | — | — | EP | claimed |
| US-20180353521-A1 | METHOD FOR TREATING STROKE OR REDUCING NERVE INJURY | Arjil Biotech Holding Company Limited (TW) | 2018-12-13 | — | — | US | claimed |
| US-20180353520-A1 | METHOD FOR TREATING STROKE OR REDUCING NERVE INJURY | Arjil Biotech Holding Company Limited (TW) | 2018-12-13 | — | — | US | claimed |
| US-20160151435-A1 | PHARMACEUTICAL COMPOSITION ADJUVANT TO CHEMOTHERAPY DRUGS AND APPLICATIONS THEREOF | BALAY BIOTECHNOLOGY CORPORATION (TW) | 2016-06-02 | — | — | US | claimed |
| CN-104606260-A | Pharmaceutical composition for assisting chemotherapy drugs and application thereof | ENYANG BIOTECHNOLOGY CO LTD | 2015-05-13 | — | — | CN | claimed |
| US-8791156-B2 | Polyacetylene compound, an extract containing the same and application thereof | NATIONAL CHUNG HSING UNIVERSITY (TW) | 2014-07-29 | — | — | US | claimed |
| US-8716499-B2 | Benzenoid compounds of antrodia cinnamomea, preparation and analysis method thereof | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2014-05-06 | — | — | US | claimed |
| US-20130150436-A1 | POLYACETYLENE COMPOUND, AN EXTRACT CONTAINING THE SAME AND APPLICATION THEREOF | NATIONAL CHUNG HSING UNIVERSITY (TW) | 2013-06-13 | — | — | US | claimed |
| US-20120178945-A1 | BENZENOID COMPOUNDS OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2012-07-12 | — | — | US | claimed |
| US-20080103195-A1 | COMPOUNDS FROM ANTRODIA CAMPHORATA FOR INHIBITING THE GROWTH OF CANCER TUMOR CELLS | GOLDEN BIOTECHNOLOGY CORPORATION (TW) | 2008-05-01 | — | — | US | claimed |
| CN-119488518-A | Application of Antrodia camphorata compound in preparing pharmaceutical composition for treating diabetes | 兰亭生物科技股份有限公司 | 2025-02-21 | — | — | CN | disclosed |
| US-7342137-B1 | Cyclohexenone compounds from Antrodia camphorata and application thereof | GOLDEN BIOTECHNOLOGY CORPORATION (TW) | 2008-03-11 | — | — | US | disclosed |
| US-20060251673-A1 | CULTIVATION METHOD AND APPLICATIONS FOR ANTRODIA CAMPHORATA | GOLDEN BIOTECHNOLOGY CORP. (TW) | 2006-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130150436-A1 | POLYACETYLENE COMPOUND, AN EXTRACT CONTAINING THE SAME AND APPLICATION THEREOF | CYP51A1, ACAT1, HADHA | CYP3A4 274/4885ALOX15 865/4885POLB 1908/4885 |
| US-20120178945-A1 | BENZENOID COMPOUNDS OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF | ACMSD, ABHD6, HRH4 | CYP3A4 192/4885ALOX15 1767/4885POLB 4421/4885 |
| US-20080103195-A1 | COMPOUNDS FROM ANTRODIA CAMPHORATA FOR INHIBITING THE GROWTH OF CANCER TUMOR CELLS | API5, CYP19A1, CYP11B1 | CYP3A4 103/4885ALOX15 377/4885POLB 3557/4885 |
| US-20180353520-A1 | METHOD FOR TREATING STROKE OR REDUCING NERVE INJURY | PMP22, NGF, NDUFB3 | CYP3A4 4225/4885ALOX15 267/4885POLB 2942/4885 |
| US-20180353521-A1 | METHOD FOR TREATING STROKE OR REDUCING NERVE INJURY | HAGH, DHCR7, HAAO | CYP3A4 1548/4885ALOX15 30/4885POLB 3642/4885 |
| US-20160151435-A1 | PHARMACEUTICAL COMPOSITION ADJUVANT TO CHEMOTHERAPY DRUGS AND APPLICATIONS THEREOF | CKMT1A; CKMT1B, ATP6V1B1, GOT1 | CYP3A4 2572/4885ALOX15 787/4885POLB 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.